|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Mar 14, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $3,825 and $5,660, respectively | ||||||||||||||||||||
| Related party receivables and prepaid expenses | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Cash held in the Trust Account | ||||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $19,155 and $11,094, respectively | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Related party long term notes receivable | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Noncurrent assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Related party payables | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Sponsor loan – promissory notes | ||||||||||||||||||||
| Franchise tax payable | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Obligation for claim payment | ||||||||||||||||||||
| Current portion of finance lease liabilities | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| FPS liability | ||||||||||||||||||||
| Related party notes payable | ||||||||||||||||||||
| Long-term debt, net of current maturities | ||||||||||||||||||||
| Finance lease liabilities, net of current portion | ||||||||||||||||||||
| Net defined benefit liability | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Long-term income tax liabilities | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Noncurrent liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Class A common stock subject to possible redemption, 706,319 and 2,960,098 shares issued and outstanding at redemption value of $10.80 and $10.53 per share as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock, par value of $0.0001 per share; 400,000,000 shares authorized; 11,778,409 shares issued and outstanding as of June 30, 2026 and 11,755,434 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 1,250,000 and 6,250,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Preferred stock, par value of $0.0001 per share; 20,000,000 shares authorized; none issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Predecessor's net parent investment | ||||||||||||||||||||
| Accumulated other comprehensive profit: | ||||||||||||||||||||
| Foreign currency translation adjustment | ||||||||||||||||||||
| Unrealized pension actuarial gains, net of tax | ||||||||||||||||||||
| Total accumulated other comprehensive profit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholder's equity | ||||||||||||||||||||
Loading...
